Induction of RANTES/CCL5 by herpes simplex virus is regulated by nuclear factor κB and interferon regulatory factor 3

References

1. Casola A., Garofalo R. P., Haeberle H., Elliott T. F., Lin R., Jamaluddin M., Brasier A. R. 2001; Multiple cis regulatory elements control RANTES promoter activity in alveolar epithelial cells infected with respiratory syncytial virus. J Virol 75:6428–6439
   [Google Scholar]
2. Eo S. K., Lee S., Chun S., Rouse B. T. 2001; Modulation of immunity against herpes simplex virus infection via mucosal genetic transfer of plasmid DNA encoding chemokines. J Virol 75:569–578
   [Google Scholar]
3. Genin P., Algarte M., Roof P., Lin R., Hiscott J. 2000; Regulation of RANTES chemokine gene expression requires cooperativity between NF- κ B and IFN-regulatory factor transcription factors. J Immunol 164:5352–5361
   [Google Scholar]
4. Kujime K., Hashimoto S., Gon Y., Shimizu K., Horie T. 2000; p38 mitogen-activated protein kinase and c-Jun-NH₂-terminal kinase regulate RANTES production by influenza virus-infected human bronchial epithelial cells. J Immunol 164:3222–3228
   [Google Scholar]
5. Lin R., Heylbroeck C., Genin P., Pitha P. M., Hiscott J. 1999; Essential role of interferon regulatory factor 3 in direct activation of RANTES chemokine transcription. Mol Cell Biol 19:959–966
   [Google Scholar]
6. Luster A. D. 1998; Chemokines – chemotactic cytokines that mediate inflammation. N Engl J Med 338:436–445
   [Google Scholar]
7. Malmgaard L., Paludan S. R., Mogensen S. C., Ellermann-Eriksen S. 2000; Herpes simplex virus type 2 induces secretion of IL-12 by macrophages through a mechanism involving NF- κ B. J Gen Virol 81:3011–3020
   [Google Scholar]
8. Melchjorsen J., Pedersen F. S., Mogensen S. C., Paludan S. R. 2002; Herpes simplex virus selectively induces expression of the CC chemokine RANTES/CCL5 in macrophages through a mechanism dependent on PKR and ICP0. J Virol 76:2780–2788
   [Google Scholar]
9. Paludan S. R. 2001; Requirements for the induction of interleukin-6 by herpes simplex virus-infected leukocytes. J Virol 75:8008–8015
   [Google Scholar]
10. Paludan S. R., Ellermann-Eriksen S., Mogensen S. C. 1998; NF- κ B activation is responsible for the synergistic effect of herpes simplex virus type 2 infection on interferon- γ -induced nitric oxide production in macrophages. J Gen Virol 79:2785–2793
    [Google Scholar]
11. Paludan S. R., Ellermann-Eriksen S., Kruys V., Mogensen S. C. 2001; Expression of TNF- α by herpes simplex virus-infected macrophages is regulated by a dual mechanism: transcriptional regulation by NF- κ B and activating transcription factor 2/Jun and translational regulation through the AU-rich region of the 3′ untranslated region. J Immunol 167:2202–2208
    [Google Scholar]
12. Pazdrak K., Olszewska-Pazdrak B., Liu T., Takizawa R., Brasier A. R., Garofalo R. P., Casola A. 2002; MAPK activation is involved in posttranscriptional regulation of RSV-induced RANTES gene expression. Am J Physiol Lung Cell Mol Physiol 283:L364–L372
    [Google Scholar]
13. Preston C. M., Harman A. N., Nicholl M. J. 2001; Activation of interferon response factor-3 in human cells infected with herpes simplex virus type 1 or human cytomegalovirus. J Virol 75:8909–8916
    [Google Scholar]
14. Sin J. I., Kim J. J., Pachuk C., Satishchandran C., Weiner D. B. 2000; DNA vaccines encoding interleukin-8 and RANTES enhance antigen-specific Th1-type CD4⁺T-cell-mediated protective immunity against herpes simplex virus type 2 in vivo. J Virol 74:11173–11180
    [Google Scholar]
15. Skoldenberg B. 1996; Herpes simplex encephalitis. Scand J Infect Dis Suppl 100:8–13
    [Google Scholar]
16. tenOever B. R., Servant M. J., Grandvaux N., Lin R., Hiscott J. 2002; Recognition of the measles virus nucleocapsid as a mechanism of IRF-3 activation. J Virol 76:3659–3669
    [Google Scholar]
17. Tumpey T. M., Cheng H., Cook D. N., Smithies O., Oakes J. E., Lausch R. N. 1998; Absence of macrophage inflammatory protein-1 α prevents the development of blinding herpes stromal keratitis. J Virol 72:3705–3710
    [Google Scholar]
18. Whitley R. J., Roizman B. 2001; Herpes simplex virus infections. Lancet 357:1513–1518
    [Google Scholar]